Last update: Oct. 15, 2015
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
First generation alkylamine-antihistamine drug, with sedative effect. Active isomer of Chlorpheniramine.
Likely inhibition of lactation within the first weeks of post-natal period because of an anti-prolactin effect.
Short-term and low dose treatment is compatible with breastfeeding. Be aware of somnolence in the child. For long-term treatments an alternative drug should be preferred.
Compounds in association with expectorants, corticoids and cough relief medicines are commercially available. Avoid drug associations especially while breastfeeding.
Follow-up on sedation and feeding ability of the infant.
Bed-sharing is not recommended for mothers who are taking this medication.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM